Ab­b­Vie, En­do hit with sub­poe­nas amid Texas AG's at­tempts to lim­it med­ical care for trans youth

Texas of­fi­cials are now in­ves­ti­gat­ing Ab­b­Vie and En­do Phar­ma­ceu­ti­cals as part of the state’s broad­er ef­fort to re­strict gen­der-af­firm­ing care for trans­gen­der chil­dren.

The Texas …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER